News | April 14, 2009

AHA Funds Three Research Centers to Study Generation of Cardiac Muscle Cells

April 14, 2009 - Three research centers have been awarded funding from the American Heart Association, with support from the Jon Holden DeHaan Foundation, to study the development and mechanisms of generating new cardiac muscle cells.

The centers will be conducting studies over the next four years to ultimately determine how regeneration of those cells can help improve outcomes for heart attack and heart failure patients.

The grants, totaling $6 million, have been awarded to the following facilities, which will each become home to an American Heart Association-Jon Holden DeHaan Foundation Cardiac Myogenesis Research Center:

-- University of Pennsylvania, Philadelphia, PA. - Center Director:
Jonathan Epstein, M.D.
-- University of Texas Southwestern Medical Center, Dallas, TX -
Center Director: Eric Olson, Ph.D.
-- University of Minnesota, Minneapolis, MN - Center Director: Doris
Taylor, Ph.D.

Each center will undertake a number of basic science research projects specifically looking at cardiac myocytes, or heart cell muscles, to learn more about how those cells biologically develop, integrate and work. Ideally, findings from this research will lead to new ways for treating various forms of heart disease, including heart attacks, congenital heart disease and heart failure.

Some of the research will focus on developing methods to identify stems cells from the heart or other organs, such as bone marrow, to give back to the patient in a way that will sustain long-lasting recovery of cardiac function. The research will build the foundation for future use of adult stem cells for regenerating and repairing heart muscle, as well as for developing new therapies and drugs in the fight against heart disease.

Thee awards are effective April 1, 2009, and will be funded through March 31, 2012.

For more information: www.americanheart.org

Related Content

ProxiCor Extracellular Matrix Reduces Complications, Readmissions Following Pericardial Reconstruction
News | Stem Cell Therapies | April 19, 2019
Aziyo Biologics Inc. announced the publication of results from its landmark RECON study in the Journal of...
FDA Releases Final Guidances on Regenerative Medicine Therapies
News | Stem Cell Therapies | March 04, 2019
The U.S. Food and Drug Administration (FDA) recently finalized two guidance documents regarding regenerative medicine...
Heart Muscle Cells Created From Stem Cells Beat in Sync
News | Stem Cell Therapies | February 01, 2019
A team of Rutgers scientists have taken an important step toward the goal of making diseased hearts heal themselves – a...
FDA Clamps Down on Unapproved Stem Cell Therapies
News | Stem Cell Therapies | December 20, 2018
December 20, 2018 — The U.S.
Secant Introduces First Synthetic Regenerative Cardiovascular Graft for CABG
News | Stem Cell Therapies | January 17, 2018
Secant Group, in partnership with its sister company SanaVita Medical, announced new technology to advance...
News | Stem Cell Therapies | October 24, 2017
October 24, 2017 — Roche and Ncardia have reached a broad licensing agreement whereby Roche and its affiliate compani
BioCardia Announces 12-Month Results from TRIDENT Trial of Stem Cell Delivery System
News | Stem Cell Therapies | September 26, 2017
BioCardia Inc. recently announced 12-month results from the Phase II TRIDENT clinical trial, conducted by the...
New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies | August 04, 2017
In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing colonies of...

An example of porcine cartdiac stem cells. Photo from the University of Miami Miller School of Medicine.

 

News | Stem Cell Therapies | June 12, 2017
June 12, 2017 — Heart muscle is one of the least renewable tissues in the body, which is one of the reasons that hear
Overlay Init